Corrie Painter, Ph.D., and Eliezer Van Allen, M.D., discuss the current state of genetic testing for cancer patients in the clinic as well as highlight efforts to tap into the full potential of genome-based medicine. #CIM20 #CRIwebinar [ Ссылка ]
A former CRI fellow from 2012-2015, Dr. Corrie Painter is currently the associate director of operations and scientific outreach in the Cancer Program of the Broad Institute of MIT and Harvard. Dr. Corrie Painter also serves as the associate director of Count Me In, which launches patient-driven research projects across multiple cancer types.
Dr. Eliezer Van Allen is an assistant professor of medicine at Harvard Medical School, a clinician at Dana-Farber/Partners Cancer Care, and an associate member at the Broad Institute of MIT and Harvard. His research focuses on computational cancer genomics, the application of new molecular profiling technologies to advance precision cancer medicine, and studying resistance to cancer therapeutics.
The “Cancer Immunotherapy and You” webinar series is produced by the Cancer Research Institute and is hosted by our science writer, Arthur Brodsky, Ph.D. The 2020 series is made possible with generous support from Bristol-Myers Squibb, Alkermes, and Foundation Medicine.
This webinar was presented during the 8th Annual Cancer Immunotherapy Month™ in June 2020, hosted by the Cancer Research Institute. Help us raise awareness of the lifesaving potential of immunotherapy for all types of cancer. Let's fuel the next scientific discoveries and breakthrough treatments through learning, engagement, and storytelling. [ Ссылка ]
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. [ Ссылка ]
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
